stockrowVSee Health, Inc.
VSEE Healthcare Health Information Services
VSee Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.6 million, up 40.3% from fiscal 2024.
- Revenue
- −53.9%
- EPS
- +109.9%
- Free cash flow
- −257.6%
- Total debt
- +31.6%
Quarter to June 2026, against a year earlier
Follow VSEE
Alert me
VSee Health, Inc. (VSEE) EV/Sales
As of 5 November 2026, VSee Health, Inc. (VSEE) trades at a EV/Sales of 0.1×. Over the past ten years it has ranged from 0.0× (March 2024) to 13.2× (June 2024); the current reading is higher than 48% of that period. That is below the Health Information Services industry median of 2.6× and below the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.2× | (84.47%) |
| FY2024 | 1.4× | — |
| FY2023 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.5× | (34.47%) |
| Mar 2026 | 0.8× | 274.08% |
| Dec 2025 | 0.2× | (70.19%) |
| Sep 2025 | 0.7× | (49.52%) |
| 9 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ACON Aclarion, Inc. compare | −98.0× |
| HLTHQ Cue Health Inc. compare | −1.1× |
| ZCMD Zhongchao Inc. compare | −0.5× |
| WORX SCWorx Corp. compare | −0.3× |
| MNDR Mobile-health Network Solutions compare | n/m |
| VSEE VSee Health, Inc. | 0.1× |
| HCTI Healthcare Triangle, Inc. compare | 0.4× |
| MGRX Mangoceuticals, Inc. compare | 9.6× |
| MSPR MSP Recovery, Inc. compare | 27.0× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)